With the analysis among 1,492 patents, we discovered top 213 key players by total patent application. Bristol Myers Squibb Co., Achillion Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc. are dominant in this area. They take 31.50% of the total patent filing.
New York, United States
Patent: 330
Achillion Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 74
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 66
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 51
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 48
Portola Pharamceuticals, Inc.
California, United States
Patent: 32
F. Hoffmann-La Roche Ltd.
Pennsylvania, United States
Patent: 28
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 26
Ohio, United States
Patent: 25
With the analysis among 25 patents, we discovered top 10 start-ups by total patent application. Oncoc4 Inc, ILIAS Biologics, Inc., Ophirex, Inc. are active in this area.
undefined undefined
Patent: 7
California, United States
Patent: 4
Utah, United States
Patent: 3
Spiral Therapeutics, Inc.
California, United States
Patent: 2
Institut National de la Santé et de la Recherche Médicale
NiKang Therapeutics, Inc.
Delaware, United States
Patent: 1
LEEDS, United Kingdom
Patent: 1
With the analysis among related 356 patents applied in the last 5 years. We discover 80 most active companies in this area. The fast-growing BioCryst Pharmaceuticals, Inc., Achillion Pharmaceuticals, Inc., Bristol Myers Squibb Co. take 38.48% of patent filing during this period.
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 60
Achillion Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 42
New York, United States
Patent: 35
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 14
Antwerpen, Belgium
Patent: 14
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 13
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 13
Indiana, United States
Patent: 12
LEEDS, United Kingdom
Patent: 11
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Guangdong Sheng, China
Patent: 9
With the analysis among related 356 patents in last 5 years, we discover 52 new entrants. IU Ventures, University of Leeds, Shenzhen Salubris Pharmaceuticals Co., Ltd. are the most active new entrants in this area.
Indiana, United States
Patent: 12
LEEDS, United Kingdom
Patent: 11
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Guangdong Sheng, China
Patent: 9
Nanjing Mingde New Drug Research and Development Co., Ltd.
Jiangsu Sheng, China
Patent: 7
Massachusetts, United States
Patent: 5
Janssen Pharmaceuticals, Inc.
New Jersey, United States
Patent: 3
Utah, United States
Patent: 3
Shanghai Meiyue Biotechnology Dev Co Ltd
Shanghai Shi, China
Patent: 3
With the analysis among 107 patents, we discovered top 37 universities and scientific research institutions by total patent application. University of Leeds, Julius-Maximilians-Universität Würzburg, Boston University are dominant in this area. They take 26.17% of the total patent filing.
LEEDS, United Kingdom
Patent: 11
Julius-Maximilians-Universität Würzburg
Massachusetts, United States
Patent: 5
Washington University in St. Louis
Missouri, United States
Patent: 5
The Johns Hopkins University
New Hampshire, United States
Patent: 2
Chengdu University of Technology
Sichuan Sheng, China
Patent: 2
Université Catholique de Louvain
Vlaams-Brabant, Belgium
Patent: 2